Copyright
©The Author(s) 2023.
World J Gastrointest Pathophysiol. Mar 22, 2023; 14(2): 34-45
Published online Mar 22, 2023. doi: 10.4291/wjgp.v14.i2.34
Published online Mar 22, 2023. doi: 10.4291/wjgp.v14.i2.34
Variable | Total cohort (n = 34) | Survived (n = 24) | In-hospital death (n = 10) | P value |
Demographics | ||||
Age (mean ± SD) | 52 ± 11.6 | 50 ± 10.5 | 57 ± 12.9 | 0.107 |
Sex | ||||
Male | 29 (85) | 22 (92) | 7 (70) | 0.104 |
Female | 5 (15) | 2 (8) | 3 (30) | |
Cause of cirrhosis | ||||
Alcohol related | 22 (65) | 15 (63) | 7 (70) | 0.938 |
Non-alcohol related | 12 (35) | 9 (37) | 3 (30) | |
Child-Pugh grade | ||||
A | 3 (9) | 3 (12) | 0 | 0.022 |
B | 19 (56) | 16 (67) | 3 (30) | |
C | 12 (35) | 5 (20) | 7 (70) | |
Risk prediction scores | ||||
APACHE II (mean ± SD) | 13.4 ± 4.7 | 11.4 ± 3.3 | 18.3 ± 3.8 | 0.196 |
BOTEM (mean ± SD) | 5.4 ± 1.1 | 5.0 ± 0.9 | 6.3 ± 0.7 | 0.964 |
CABIN (mean ± SD) | 10.9 ± 5.0 | 8.3 ± 1.8 | 17.0 ± 3.8 | 0.133 |
CHILD-PUGH (mean ± SD) | 8.9 ± 1.8 | 8.2 ± 1.8 | 10.6 ± 2.0 | 0.001 |
EMORY (mean ± SD) | 3.2 ± 0.9 | 2.8 ± 0.7 | 4.3 ± 0.5 | 0.497 |
FIPS (mean ± SD) | -0.3 ± 0.9 | -0.6 ± 0.9 | 0.5 ± 0.5 | 0.205 |
MELD (mean ± SD) | 15.0 ± 6.2 | 13 ± 4.8 | 19.8 ± 6.7 | 0.007 |
MELD-Na (mean ± SD) | 16.9 ± 7.4 | 14 ± 5.3 | 23.9 ± 7.1 | < 0.001 |
In-hospital deaths | ||||
AUC | STD error | P value | 95% confidence interval | |
APACHE II | 0.948 | 0.035 | 0 | 0.879–1.000 |
BOTEM | 0.877 | 0.059 | 0.001 | 0.762–0.992 |
CABIN | 0.967 | 0.028 | 0 | 0.912–1.000 |
CHILD-PUGH | 0.802 | 0.084 | 0.006 | 0.638–0.967 |
EMORY | 0.942 | 0.038 | 0 | 0.868–1.000 |
FIPS | 0.892 | 0.055 | 0 | 0.783–1.000 |
MELD | 0.792 | 0.082 | 0.008 | 0.631–0.952 |
MELD Na | 0.865 | 0.077 | 0.001 | 0.713–1.000 |
Ref. | Country | No. of patients | C-P grade A/B/C | Initial control of bleeding % | 30-d mortality % | Persistent/Recurrent rebleeding | Survival % | Prognostic factors |
Azoulay et al[22], 2001 | France | 58 | 3/8/47 | 90 | 29 | 17 | 51.7 (12 mo) | Sepsis, vasoactive drugs, balloon tamponade |
Bañares et al[23], 1998 | Spain | 56 | 11/22/23 | 95 | 28 | 22 (1 mo) | 72 (30 d) | Ascites, HE, albumin |
Barange et al[24], 1999 | France | 32 | 3/14/15 | 90 | 25 | 14 | 75 (30 d) | ND |
Bizollon et al[25], 2001 | France | 28 | 0/11/17 | 96 | 25 (40 d) | 18 | 52 (2 yr) | ↑Creatinine, ↑bilirubin |
Casadaban et al[26], 2015 | United States | 101 | 2/46/52 | 89 | 31 | 21 | 44 (12 mo) | ↑Bilirubin, ↑creatinine, ↑INR, non-alcoholic liver disease |
Chau et al[27], 1998 | England | 84 | 4/17/63 | 98 | 34 | 30 (30 d) | 66 (30 d) | ND |
Encarnacion et al[28], 1995 | United States | 64 | 2/32/31 | 98 | 19 | 29 (6 mo) | 56 (12 mo) | Haemodynamic instability |
Gazzera et al[29], 2012 | Italy | 82 | ND | 94 | 25.6 | 13.4 | 74.4 (30d) | Child-Pugh C, ↑creatinine, ↑PT |
Gerbes et al[30], 1998 | Germany | 11 | 91 | 27 | 27 | 73 (12 mo) | ND | |
Helton et al[31], 1993 | United States | 23 | 0/15/18 | 74 | 56 (in hospital) | 39 | ND | Emergency TIPS, active bleeding |
Hermie et al[32], 2018 | Belgium | 32 | ND/ND/14 | 97 | 31 | 0 | 69 | MELD > 19, Haemodynamic instability |
Jabbour et al[33], 1996 | United States | 25 | ND/ND/8 | 96 | 44 | ND | 56 (30 d) | Child-Pugh C, urgent TIPS |
Jalan et al[34], 1995 | Scotland | 19 | 3/3/13 | 100 | 42 | 15.6 | 58 (30 d) | Liver failure, sepsis |
Maimone et al[36], 2019 | England | 144 | 11/55/78 | ND | 36 (6 wk) | 29 | 64 (6 wk) | ↑MELD, ↑Child-Pugh score |
Le Moine et al[35], 1994 | Belgium | 24 | 3/13/9 | 96 | 17 | 25 | 29 (5 mo) | ND |
McCormick et al[37], 1994 | England | 20 | 1/7/12 | 100 | 60 (40 d) | 40 | 30 | ND |
Patch et al[38], 1998 | England | 54 | 5/20/29 | 91 | 48 (6 wk) | 11 | 53 (6 mo) | Ventilation, ↑WBC, platelets, ↑creatinine |
Rubin et al[39], 1995 | United States | 49 | 3/23/23 | 84 | 40% | 16 | ND | C-P grade C, APACHE II > 18 |
Sanyal et al[40], 1996 | United States | 30 | 1/7/22 | 100 | 37 | 7 | 60 (6 wk) | > 70 yr, bilirubin >6 mg/dL, creatinine > 3 mg/dL, HE, ARDS |
Tyburski et al[41], 1997 | United States | 33 | 0/5/28 | ND | 27 | 15 | 58 (12 mo) | Albumin < 2.5 g/dL, bilirubin > 3 mg/dL, PT > 15 s |
Tzeng et al[42], 2009 | Taiwan | 107 | ND | ND | 28 | ND | 50 (12 mo) | C-P score > 11, MELD > 20 |
Zhu et al[43], 2019 | China | 58 | 5/36/7 | 91.2 | 12.3 (6 wk) | 10.5 (6 wk) | 81.8 (12 mo) | Ventilation, ICU |
- Citation: Krige J, Jonas E, Robinson C, Beningfield S, Kotze U, Bernon M, Burmeister S, Kloppers C. Novel CABIN score outperforms other prognostic models in predicting in-hospital mortality after salvage transjugular intrahepatic portosystemic shunting. World J Gastrointest Pathophysiol 2023; 14(2): 34-45
- URL: https://www.wjgnet.com/2150-5330/full/v14/i2/34.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v14.i2.34